Of significance in patients, AD risk is significantly elevated through compromised microglial function and reduced Aβ clearance related to rare mutations in the TREM2 gene (Guerreiro et al., 2013; Jonsson et al., 2013), leading to Aβ accumulation. The gene discussed is TREM2; the disease is Alzheimer disease.